scispace - formally typeset
Journal ArticleDOI

Worldwide access to treatment for end-stage kidney disease: a systematic review.

Thaminda Liyanage, +19 more
- 16 May 2015 - 
- Vol. 385, Iss: 9981, pp 1975-1982
Reads0
Chats0
TLDR
The large number of people receiving RRT and the substantial number without access to it show the need to both develop low-cost treatments and implement effective population-based prevention strategies.
About: 
This article is published in The Lancet.The article was published on 2015-05-16. It has received 1384 citations till now. The article focuses on the topics: End stage renal disease.

read more

Citations
More filters
Journal ArticleDOI

Canagliflozin and cardiovascular and renal events in type 2 diabetes

Bruce Neal, +10 more
- 12 Jun 2017 - 
TL;DR: Patients treated with canagliflozin had a lower risk of cardiovascular events than those who received placebo but a greater risk of amputation, primarily at the level of the toe or metatarsal.
Journal ArticleDOI

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Vlado Perkovic, +30 more
- 14 Apr 2019 - 
TL;DR: In patients with type 2 diabetes and kidney disease, the risk of kidney failure and cardiovascular events was lower in the canagliflozin group than in the placebo group at a median follow-up of 2.62 years.
Journal ArticleDOI

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Boris Bikbov, +221 more
- 29 Feb 2020 - 
TL;DR: The burden of CKD was much higher than expected for the level of development, whereas the disease burden in western, eastern, and central sub-Saharan Africa, east Asia, south Asia, central and eastern Europe, Australasia, and western Europe was lower than expected.
Journal ArticleDOI

Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy

Adeera Levin, +25 more
- 21 Oct 2017 - 
TL;DR: An action plan and performance framework based on ten themes to strengthen CKD surveillance, tackle major risk factors for CKD, and enhance understanding of the genetic causes of CKD is presented.
Journal ArticleDOI

SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis

Brendon L. Neuen, +17 more
- 01 Nov 2019 - 
TL;DR: Evidence is provided that the proportional effect of SGLT2 inhibitors might attenuate with declining kidney function and there was clear, separate evidence of benefit for all eG FR subgroups, including for participants with a baseline eGFR 30-45 mL/min per 1·73 m2.
References
More filters
Journal ArticleDOI

Meta-analysis of observational studies in epidemiology - A proposal for reporting

Donna F. Stroup, +10 more
- 19 Apr 2000 - 
TL;DR: A checklist contains specifications for reporting of meta-analyses of observational studies in epidemiology, including background, search strategy, methods, results, discussion, and conclusion should improve the usefulness ofMeta-an analyses for authors, reviewers, editors, readers, and decision makers.
Journal ArticleDOI

Global Prevalence of Diabetes: Estimates for the year 2000 and projections for 2030

Sarah H. Wild, +4 more
- 01 May 2004 - 
TL;DR: Findings indicate that the "diabetes epidemic" will continue even if levels of obesity remain constant, and given the increasing prevalence of obesity, it is likely that these figures provide an underestimate of future diabetes prevalence.
Journal ArticleDOI

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

Rafael Lozano, +195 more
- 15 Dec 2012 - 
TL;DR: The Global Burden of Diseases, Injuries, and Risk Factors Study 2010 aimed to estimate annual deaths for the world and 21 regions between 1980 and 2010 for 235 causes, with uncertainty intervals (UIs), separately by age and sex, using the Cause of Death Ensemble model.
Journal ArticleDOI

Global burden of hypertension: analysis of worldwide data

Patricia M. Kearney, +6 more
- 15 Jan 2005 - 
TL;DR: The overall prevalence and absolute burden of hypertension in 2000 and the global burden in 2025 were estimated to be about 1.56 billion (1.54-1.58 billion) and the number of adults with hypertension in 2025 was predicted to increase by about 60% respectively.
Journal ArticleDOI

Alternatives for logistic regression in cross-sectional studies: an empirical comparison of models that directly estimate the prevalence ratio

Aluísio J D Barros, +1 more
- 20 Oct 2003 - 
TL;DR: Cox or Poisson regression with robust variance and log-binomial regression provide correct estimates and are a better alternative for the analysis of cross-sectional studies with binary outcomes than logistic regression, since the prevalence ratio is more interpretable and easier to communicate to non-specialists than the odds ratio.
Related Papers (5)

Chronic kidney disease: global dimension and perspectives

Vivekanand Jha, +10 more
- 20 Jul 2013 - 

Global Prevalence of Chronic Kidney Disease - A Systematic Review and Meta-Analysis.

Nathan R. Hill, +6 more
- 06 Jul 2016 - 

US Renal Data System 2016 Annual Data Report: Epidemiology of Kidney Disease in the United States

Rajiv Saran, +85 more
- 01 Mar 2017 - 

Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015

Haidong Wang, +844 more
- 08 Oct 2016 - 

Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

Boris Bikbov, +221 more
- 29 Feb 2020 -